Johnson & Johnson

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7bl mega deal

Last week, U.S. Health and Human Services Secretary Robert F. Kennedy Jr acknowledged there is no evidence

November 3, 2025 19:27 IST

Johnson & Johnson faces UK lawsuit from thousands over cancer-causing material in baby powder

Johnson & Johnson baby powder lawsuit: J&J faced its first UK lawsuit after 3000 people claimed cancer-causing substances in talcum…

October 18, 2025 10:31 IST

The controversy revolves around the ongoing litigation. Families sued, claiming that Tylenol use during pregnancy contributed to autism or attention-deficit hyperactivity disorder.

Bombshell memo claims Johnson & Johnson admitted to Tylenol-Autism link years ago

A new report seems to have undone years-old internal Johnson & Johnson discussions about the potential adverse link between Tylenol…

Updated: September 27, 2025 13:52 IST

The Dark Secrets of Johnson & Johnson, book review, lifestyle, life

Book Review | Trust on trial: Gardiner Harris writes on Johnson & Johnson’s ‘dark secrets’

How J&J was peddling not just baby powder but also lies that cost many lives

August 16, 2025 22:00 IST

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal

The deal would help accelerate growth in J&J’s drugs business after the company spun off its consumer health unit in…

Updated: January 14, 2025 07:47 IST

Johnson & Johnson’s subcutaneous Tremfya holds potential to set new standard in Crohn’s disease treatment

According to GlobalData’s Sales and Forecast database, total sales for Tremfya are expected to reach $7.8 billion globally by 2029.

October 21, 2024 16:56 IST

Johnson & Johnson, talcum powder, talcum powder cancer, healthcare news,

Johnson & Johnson’s bone cancer drug gets USFDA nod

Multiple myeloma is an incurable blood cancer that affects a type of white blood cell called plasma cells, which are…

April 8, 2024 18:05 IST

J&J slides as device margins droop, drug sales seen falling

Sales of hip equipment were $398 million, while knee devices sold $387 million, both beating analysts’ estimates.

January 24, 2024 16:48 IST

Johnson & Johnson, myopia, eye disorder, healthcare news,

Johnson & Johnson Vision introduces new procedure for patients with myopia

According to the company, refractive surgery can correct myopia, allowing patients to clearly see distant objects without glasses or contacts…

September 25, 2023 12:54 IST

Johnson & Johnson, appointments, company announcements, healthcare news,

Johnson & Johnson Medtech India appoints Anuj Virmani as managing director

His priorities as the Managing Director of Johnson & Johnson MedTech India encompass ethical leadership, nurturing talent, and reinforcing the…

July 25, 2023 11:21 IST

Johnson & Johnson, Talcum powder, cancer, healthcare news, pharma news,

Johnson & Johnson to pay $8.9 billion to settle talc-cancer lawsuits

Women and men blamed J&J’s 129-year-old baby powder for causing ovarian cancer and mesothelioma, a cancer specifically tied to asbestos…

April 5, 2023 12:46 IST

Johnson & Johnson, Janssen, dengue, dengue virus, healthcare news, pharmaceuticals news,

Janssen’s novel Dengue antiviral demonstrates ‘strong protection’ in pre-clinical data

Despite the global burden of dengue, and the fact that reinfection is possible due to the presence of four dengue…

March 16, 2023 14:26 IST

Spectrum Pharmaceuticals, USFDA, lung cancer drug, poziotinib, Luye Pharma, health news, pharma news,

USFDA approves Johnson & Johnson’s blood cancer therapy, Tecvayli

TECVAYLI is Janssen’s fourth approved treatment for multiple myeloma and this further diversifies the company’s industry-leading oncology portfolio and deepens…

October 26, 2022 12:16 IST

Johnson & Johnson, talcum powder, cancer, cancer research, cancer news, health news, pharma news,

Cancer victims suing Johnson & Johnson over talc products urge court to end bankruptcy roadblock

Johnson & Johnson which maintains its talc products are safe, spun off LTL in October, assigned its talc liabilities to…

September 20, 2022 16:06 IST

Johnson & Johnson, pelvic mesh, ethicon, legal suit, health news, pharma news,

Johnson & Johnson reaches $205 million settlement in Australian pelvic mesh class action

Reportedly, J&J has also faced similar lawsuits in the United States, Canada, and Europe. Earlier this year, a California court…

September 12, 2022 14:12 IST

Johnson & Johnson to pay $40.5 million to settle opioid epidemic lawsuit

In a statement, J&J did not admit wrongdoing, and called its marketing and promotion of prescription opioids “appropriate and responsible.”

September 1, 2022 21:45 IST

Johnson & Johnson to end global sales of talc-based baby powder

“As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby…

Updated: August 12, 2022 16:37 IST

Johnson & Johnson’s cancer drug sales ease hit from stronger dollar

The company’s COVID-19 vaccine, which has seen slow demand due to safety concerns and productions hurdles, brought in sales of…

July 20, 2022 19:09 IST

Related News

Reliance Group has distanced itself from Reliance Communications and Anil Ambani

Reliance Group and Anil Ambani distance from Rel Comm, say ‘attached assets belong to Reliance Communications’

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

A TCS employee based in Mumbai has emerged victorious after being forced to resign while attending to his father in the ICU, highlighting issues of employee rights and company accountability.

TCS asked to pay full gratuity to employee forced to resign after Labour comm steps in

Railway RRB NTPC UG Result 2025 Date, Time LIVE Updates: Results are OUT; check all imp details here

US tourist visa: Applicant’s B1/B2 visa approved without hassle, officer says ‘I don’t need to…’

‘You can reach space faster’: Shubhanshu Shukla’s take on Bengaluru traffic goes viral

India News52 min ago

Bengaluru’s traffic issues have resurfaced after astronaut Shubhanshu Shukla revealed his lengthy commute to a tech summit. The state government has promised to tackle the city’s infrastructure problems, following discussions with top business leaders. Shukla’s comment, based on his experience on the International Space Station, has sparked renewed debate on the state of Bengaluru’s traffic.

View all shorts